TG Therapeutics TGTX Operating Lease ROU Assets
Operating Lease ROU Assets at other companies
Other financials
Where this comes from
Reported directly by TG Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.
The official record: TG Therapeutics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about TG Therapeutics's operating lease rou assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is TG Therapeutics's operating lease ROU assets?
- TG Therapeutics (TGTX) reported operating lease ROU assets of $6.48M in Q1 2026.
- How has TG Therapeutics's operating lease ROU assets changed year-over-year?
- TG Therapeutics's operating lease ROU assets decreased by 6.4% year-over-year, from $6.93M to $6.48M.
- What is the long-term trend for TG Therapeutics's operating lease ROU assets?
- Over 5 years (2020 to 2025), TG Therapeutics's operating lease ROU assets has grown at a -7.6% compound annual growth rate (CAGR), from $9.31M to $6.28M.
- What does operating lease ROU assets mean?
- The balance sheet value representing the company's right to use leased assets like offices or equipment.
- How do you interpret operating lease ROU assets?
- Changes reflect the expansion or contraction of the company's physical footprint and long-term operational commitments.
- How does operating lease ROU assets compare across companies?
- Standard for all companies with significant physical infrastructure; comparable across industries under modern lease accounting.